Abstract: Recent studies mainly deal with the relevance of antibiotics in the treatment of complicated skin and soft tissue infections (cSSTIs) with or without sepsis. The impact of surgical source control for severely ill patients with sepsis is underrepresented in...
Necrotizing Fasciitis
Hyperbaric Oxygen Therapy (HBOT) Research for Necrotizing Fasciitis
Fournier’s gangrene (necrotising fasciitis) complicated by renal and respiratory insufficiency: a case report.
Abstract: A case report of a 68-year-old male obese diabetic patient with an abscess of left femoral region, and diffuse inflammation of abdominal wall and genital region developing sepsis, respiratory and renal failure. At admission in the regional hospital a...
Commentary: Hyperbaric oxygen treatment for wounds – evidence and the Sword of Damocles.
Abstract: Increased access to any treatment sensibly follows the clinical and cost benefit being established. For many treatments this requires multiple, high-quality clinical trials and supporting cost analysis. Cost analysis may be applied to a single treatment or...
Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality.
Abstract: In a single-centre, retrospective, case-controlled study of patients attending the Alfred Hospital in Prahran, Victoria, we assessed the effect of hyperbaric oxygen therapy (HBOT) in reducing mortality or morbidity in patients with necrotising fasciitis (NF)...
Does hyperbaric oxygen improve survival in necrotising soft tissue infections?
Abstract: Gorman, , , , , , , , (2015). Does hyperbaric oxygen improve survival in necrotising soft tissue infections? Anaesthesia and intensive care, 2015 Nov;43(6):683-4. https://www.ncbi.nlm.nih.gov/pubmed/26603790
Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.
Abstract: New biomarkers are needed to assess the severity of necrotizing soft tissue infection (NSTI) at an early stage and to individualize treatment strategies. We assessed pentraxin-3 (PTX3) as a marker of disease severity and risk of death in patients with NSTI....
Economic outcomes in clinical studies assessing hyperbaric oxygen in the treatment of acute and chronic wounds.
Abstract: Hyperbaric oxygen treatment (HBOT) is used to treat acute and chronic wounds. This systematic review was conducted to summarise and evaluate existing evidence on the costs associated with HBOT in the treatment of wounds. We searched multiple electronic...
What’s new in wound treatment: a critical appraisal.
Abstract: With the growing demand for the specialized care of wounds, there is an ever expanding abundance of wound care modalities available. It is difficult to identify which products or devices enhance wound healing, and thus, a critical and continual look at new...
The diabetic foot in 2015: an overview.
Abstract: In 2015, it can be said that the diabetic foot is no longer the Cinderella of diabetic complications. Thirty years ago there was little evidence-based research taking place on the diabetic foot, and there were no international meetings addressing this topic....